Summary
In pithed and vagotomized rats the effects of the H3 receptor agonist R-(−)-α-methylhistamine, the H1 receptor agonist 2-(2-thiazolyl)ethylamine and the H2 receptor agonist dimaprit on basal diastolic blood pressure, basal heart rate and the electrically induced rise in heart rate were examined.
Basal diastolic blood pressure was not altered by low, but increased by high doses of R-(−)-α-methylhistamine; the latter effect was not affected by selective H1, H2 or H3 receptor antagonists and by prazosin, but was attenuated by rauwolscine. Rauwolscine also unmasked a vasodepressor response to R-(−)-α-methylhistamine not affected by the H3 receptor antagonist thioperamide, but counteracted by the H1 receptor antagonist dimetindene or the H2 receptor antagonist ranitidine. The vasodepressor responses to 2-(2-thiazolyl)ethylamine and dimaprit were antagonized by dimetindene and ranitidine, respectively. The vasodepressor response to 2-(2-thiazolyl)ethylamine was not altered by indomethacin, but reduced by an inhibitor of endothelial nitric oxide synthase, Nω-nitro-L-arginine methyl ester (which, by itself, markedly increased blood pressure). Both drug tools did not alter the effect of dimaprit. Basal heart rate was not affected by 2-(2-thiazolyl)ethylamine (examined after administration of propranolol), dimaprit and R-(−)-α-methylhistamine. The electrically induced increase in heart rate (studied in animals which had received rauwolscine) was decreased by R-(−)-α-methylhistamine but not affected by 2-(2-thiazolyl)ethylamine and dimaprit. The effect of R-(−)-α-methylhistamine was abolished by thioperamide. R-(−)-α-methylhistamine did not influence the increase in heart rate produced by isoprenaline.
In conclusion, the pithed rat offers the opportunity to study cardiac presynaptic H3 receptors, endothelial H1 receptors and vascular H2 receptors in the same experimental model. Cardiac presynaptic H1 and H2 receptors as well as postsynaptic H3 receptors in the heart and in the resistance vessels were not found. R-(−)-α-methylhistamine is a weak agonist at α2, H1 and H2 receptors.
Similar content being viewed by others
References
Armng J-M, Garbarg M, Schwartz J-C (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832–837
Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz J-C (1987) Highly potent and selective ligands for histamine H3-receptors. Nature 327:117–123
Beleslin DB (1962) The action of histamine on the blood pressure of the rat. Arch Int Pharmacodyn 138:19–31
Boudreau NJ, Vohra MM (1991) The mechanism of [3H] noradrenaline release by histamine and its analogs from the rat vas deferens. Can J Physiol Pharmacol 69:469–474
Ea-Kim L, Oudart N (1988) A highly potent and selective H3 agonist relaxes rabbit middle cerebral artery, in vitro. Eur J Pharmacol 150:393–396
Fuder H, Egenolf M, Torzewski M (1990) Inhibitory prejunctional histamine H3-receptors on noradrenergic nerves of guinea-pig atria. Naunyn-Schmiedeberg's Arch Pharmacol 341 [Suppl]:R87
Göthert M, Schlicker E, Hentrich F, Rohm N, Zerkowski HR (1984) Modulation of noradrenaline release in human saphenous vein via presynaptic α2-adrenoceptors. Eur J Pharmacol 102:261–267
Ichinose M, Barnes PJ (1989) Histamine H3-receptors modulate nonadrenergic noncholinergic bronchoconstriction in guinea-pig in vivo. Eur J Pharmacol 174:49–55
Kimura T, Satoh S (1983) Inhibition of cardiac sympathetic neurotransmission by histamine in the dog is mediated by H1 receptors. Br J Pharmacol 78:733–738
Kobinger W, Pichler L (1980) Investigation into different types of post-and presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402
Leusen J, Van de Voorde J (1988) Endothelium-dependent responses to histamine. In: Vanhoutte PM (ed) Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. Raven Press, New York, pp 469–474
Levi R, Rubin LE, Gross SS (1991) Histamine in cardiovascular function and dysfunction: recent developments. In: Uvnäs B (ed) Handbook of experimental pharmacology, vol 97. Berlin Heidelberg New York, Springer, pp 347–383
Lokhandwala MF (1978) Inhibition of sympathetic nervous system by histamine: studies with H1- and H2-receptor antagonists. J Pharmacol Exp Ther 206:115–122
Luo XX, Tan YH, Sheng BH (1991) Histamine H3-receptors inhibit sympathetic neurotransmission in guinea-pig myocardium. Eur J Pharmacol 204:311–314
Malinowska B, Schlicker E (1991) H3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur J Pharmacol 205:307–310
Malinowska B, Schlicker E, Göthert M (1992) Direct and indirect effects of histamine Hl, H2 and H3 receptor agonists on blood pressure and heart rate of the pithed rat. Pol J Pharmacol Pharm 44 [Suppl]:91
McLeod RL, Gertner SB, Hey JA (1991) Modulation of cardiovascular function by central histamine H3 receptors in conscious guinea pigs. Eur J Pharmacol 209:141–142
Molderings GJ, Weißenborn G, Schlicker E, Göthert M (1992) Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 346:46–50
Rand MJ, Story DF, Wong-Dusting HK (1982) Effects of histamine on the resting and stimulation-induced release of [3H]-noradrenaline in guinea-pig isolated atria. Br J Pharmacol 75:57–64
Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746–752
Rosic M, Collis CS, Anjelkovic IZ, Segal MB, Djuric D, Zloković BV (1991) The effects of (R)α-methylhistamine on the isolated guinea pig aorta. In: Timmerman H, van der Goot H (eds) New perspectives in histamine research. Birkhäuser, Basel, pp 283–287
Schlicker E, Betz R, Göthert M (1988) Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 337:588–590
Schlicker E, Fink K, Hinterthaner M, Göthert M (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340:633–638
Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864–989
van Zwieten PA, Timmermans PBMWM (1983) Cardiovascular α2-receptors. J Mol Cell Cardiol 15:717–733
Vassilev P, Staneva-Stoytcheva D, Mutafova-Yambolieva V (1991) Do H3 receptors participate in the effects of histamine on electrically-evoked contractions on rat vas deferens. Gen Pharmacol 22: 643–645
Author information
Authors and Affiliations
Additional information
Correspondence to E. Schlicker at the above address
Rights and permissions
About this article
Cite this article
Malinowska, B., Schlicker, E. Identification of endothelial H1, vascular H2 and cardiac presynaptic H3 receptors in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 347, 55–60 (1993). https://doi.org/10.1007/BF00168772
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168772